SSRI
An SSRI, or selective serotonin reuptake inhibitor, is the most widely used type of antidepressant. These medicines block the transporter that carries serotonin, a chemical messenger, back into nerve cells, so more of it stays between them. How this leads to feeling better, which takes weeks, is not fully understood. Selective means they act mainly on serotonin. In the US they are approved for depression and for several anxiety conditions.
Also called: Selective serotonin reuptake inhibitor, SSRIs, SSRI antidepressants.
Written by Alena Kozlova, PhD, from published studies and prescribing information.
Definition medically reviewed by Dr. Jason Tan, Consultant Psychiatrist, on November 11, 2026, this definition only. Next review: November 11, 2027.
Which medicines are SSRIs and what do they treat?
The SSRIs are a group of medicines rather than one drug. The ones in use are sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine and citalopram. If the medicine in your cabinet is one of those, this page is about it.
Depression and anxiety, mostly. The US label for Zoloft covers major depressive disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder and premenstrual dysphoric disorder. The Lexapro label covers depression in adults and children 12 and over, and generalized anxiety disorder in adults and children 7 and over. Prozac is approved for depression, obsessive-compulsive disorder, bulimia nervosa and panic disorder.
The effect is not there on day one. NIMH says antidepressants usually take 4 to 8 weeks to work, and that sleep, appetite, energy and concentration often improve before mood lifts. The medicine acts on the transporter from the first dose; what takes weeks is the change you can feel, which is one reason early side effects often turn up before any benefit does.
Who should not take an SSRI and what are the risks?
Anyone taking a monoamine oxidase inhibitor, or who stopped one within the last 14 days, should not start an SSRI. The Zoloft label also rules it out for anyone taking pimozide and for anyone with a known allergy to sertraline, and the oral solution is ruled out with disulfiram. The Lexapro label rules out pimozide and anyone sensitive to escitalopram or citalopram.
SSRIs can also set off serotonin syndrome, which the Zoloft label calls potentially life-threatening. It usually follows a new serotonergic medicine or a dose increase. The label tells prescribers to stop the SSRI and any other serotonergic medicine immediately if it happens, so this is a same-day call to your prescriber, not a wait-and-see. If someone becomes confused, very stiff or feverish, call 911.
Antidepressants carry a boxed warning about suicidal thoughts and behaviors in children, teenagers and young adults. NIMH puts the risk under age 25, in the first few weeks and after a dose change, which is why those weeks need someone keeping an eye on things. If something looks worse rather than different, tell your prescriber that week.
Can SSRIs make anxiety worse at first?
Starting one can make you jittery before it makes you calmer. Researchers call this the jitteriness or anxiety syndrome. A 2009 systematic review in The British Journal of Psychiatry found published incidence rates ranging from 4% to 65% of people starting an antidepressant, and concluded that the syndrome is still poorly characterised, with no robust evidence that it differs between SSRIs and older tricyclics.
A 2017 study followed 209 people starting mirtazapine, sertraline, desvenlafaxine, escitalopram or fluoxetine, five medicines from different classes, and found jitteriness in 27.7% of the whole group over six weeks and 6.7% in the first two weeks. Mirtazapine, which is not an SSRI, had the lowest rate at 14.3%, and the other four ran 23% to 34%. A higher dose raised the odds, and the Lexapro label shows the same pull on one SSRI: in the depression trials insomnia was reported by 7% of people on 10 mg and 14% of those on 20 mg, against 4% on placebo. In the generalized anxiety trials it was 12% against 6%.
The strategies named in the 2009 review were a slower increase of the dose and, for some people, adding a benzodiazepine, though the review found the evidence for both thin. Either one is your prescriber’s call, not a change to make on your own.
Which SSRI is best for anxiety?
No single one holds that title on the labels. What the labels show is which conditions each medicine was tested in. Lexapro carries the approval for generalized anxiety disorder, in adults and in children 7 and over. Zoloft carries panic disorder, social anxiety disorder, post-traumatic stress disorder and obsessive-compulsive disorder. Prozac carries panic disorder and obsessive-compulsive disorder.
So the fit depends on which kind of anxiety you have, what you have taken before, what else you take and which side effects you can live with. Those four things are worth saying out loud at the appointment, because they are what the choice turns on.
Which SSRIs are prescribed most often?
Sertraline (Zoloft) and fluoxetine (Prozac) were among the most frequently prescribed antidepressants in every year from 1996 to 2015, in an analysis of the US Medical Expenditure Panel Survey published in Frontiers in Psychiatry in 2020. It counted adults with major depression who were taking one antidepressant, and the authors put trazodone and nefazodone in the SSRI group, which held about 70% of those prescriptions across the 20 years. The figures stop at 2015.
What to do
Ask your prescriber which condition the SSRI is for and what the first two weeks are likely to feel like. Write down the date you start, the dose, and anything new in sleep, appetite or anxiety, with the day it began. If something feels worse rather than just different, tell your prescriber instead of waiting for the next appointment. If you have thoughts of harming yourself, call or text 988 in the US, or your local emergency number.
Read what the first two weeks can look like
How withClaro helps
- A daily log of how you feel, next to the dose you took
- A PDF report to hand your prescriber
- Reminders so doses do not slip
Get the withClaro app on the App Store
Related terms
Sources
- U.S. Food and Drug Administration. Zoloft (sertraline) tablets and oral solution: prescribing information. FDA / DailyMed, 2025.
- U.S. Food and Drug Administration. Lexapro (escitalopram) tablets and oral solution: prescribing information. FDA / DailyMed, 2026.
- U.S. Food and Drug Administration. Prozac (fluoxetine): prescribing information. FDA / DailyMed, 2026.
- Sinclair LI, Christmas DM, Hood SD, Potokar JP, Robertson A, Isaac A, Srivastava S, Nutt DJ, Davies SJC. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. British Journal of Psychiatry, 2009.
- Sinha P, Shetty DJ, Bairy LK, Andrade C. Antidepressant-related jitteriness syndrome in anxiety and depressive disorders: Incidence and risk factors. Asian Journal of Psychiatry, 2017.
- Luo Y, Kataoka Y, Ostinelli EG, Cipriani A, Furukawa TA. National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis. Frontiers in Psychiatry, 2020.
- U.S. Food and Drug Administration. Nardil (phenelzine sulfate) tablets: prescribing information. FDA / DailyMed, 2009.
- National Institute of Mental Health (NIMH). Mental Health Medications. NIMH, 2024.
- U.S. National Library of Medicine. Sertraline. MedlinePlus, 2025.
- National Health Service (NHS). Antidepressants: Overview. NHS, 2026.
All glossary terms